Adagene Rings the Opening Bell in Celebration of its IPO
ABOUT THIS EVENT
Adagene (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies, rings the Nasdaq Opening Bell remotely from across the country.
Peter Luo, Ph.D. Co-Founder, CEO, and Chairman of the Board, rings the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.